Table 4.
Kidney and extrarenal manifestations in ADPKD patients
| PKD manifestation | Frequency | Comments |
|---|---|---|
| Kidney | ||
| Urinary concentration defect | In up to 60% of children | Earliest manifestation |
| Hypertension | In 50-70% prior to GFR decline; Average age of onset, 30 | Screen children with family history of ADPKD from age 5, then at 3-y intervals if negative |
| ESRD | Occurs in 50% by age 60 | Mean age of onset, 58 y |
| Proteinuria (>300 mg/d) | Associated with GFR decline | Prognostic marker |
| Abdominal/Flank Pain | In 60% of adults | Acute, chronic; multiple causes |
| Nephrolithiasis | In 20-35% of patients | Uric acid, Calcium oxalate composition |
| Cyst hemorrhage/gross hematuria | In up to 60% of patients | Most resolve within 2-7 d |
| Urinary tract infection | In 30-50% of patients | More common in women |
| Renal cell carcinoma | In <1% of patients | Risk not increased, may present with systemic symptoms |
| Extrarenal | ||
| Polycystic liver disease | In >80% by age 30 | Include liver imaging in initial visit |
| Intracranial aneurysm | In 20-27% of those with positive family history of intracranial aneurysm; in 9% of those without such family history | Screen if family history of intracranial aneurysm, personal history of intracranial hemorrhage, individuals with high-risk professions, pre-transplantation |
| Arachnoid cysts | In 8-12% | Possible increased risk of spontaneous subdural hematoma |
| Mitral valve prolapse | In 25% | Screen if symptoms |
| Pericardial effusion | In up to 35% | Screen if symptoms |
| Pancreatic cysts | In 10% | No screening needed |
| Diverticulosis | In 20-25% of those with ESRD | No screening needed |
| Bronchiectasis | In up to 37% | Mild, no screening needed |
| Congenital hepatic fibrosis | rare | No screening needed |
| Seminal vesicle cysts | In up to 40% male patients | No correlation to semen abnormalities |
| Male infertility | associated with ADPKD | Abnormal semen parameters reported |
GFR, glomerular filtration rate; ADPKD, autosomal dominant polycystic kidney disease; ESRD, end-stage renal disease